YOUR CONDITION, EXPLAINED
Hodgkin's Lymphoma VA disability rating & claim guide
The VA rates Hodgkin's Lymphoma under diagnostic code 7709, in 38 CFR § 4.117 (hemic and lymphatic systems), and the schedule provides a single evaluation under it: 100%.
Free · No account needed
Save your Hodgkin's Lymphoma guide
Email yourself this Hodgkin's Lymphoma guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.
A CLEARER PATH FORWARD
Make sense of your next step.
01Understand the rating02Know what to gather03Plan your preparationTHE ESSENTIALS
How the VA rates Hodgkin's Lymphoma
DC 7709 states one evaluation, 100 percent, for Hodgkin's lymphoma with active disease or during a treatment phase. Everything else about this code is in its single note, and the note is what a veteran needs: the 100 percent continues beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy or other therapeutic procedure, and six months after that treatment is discontinued a mandatory VA examination determines the rating. If there has been no local recurrence or metastasis, the evaluation moves to the residuals, rated under whatever codes they fall under — and for this disease the residuals of treatment are often the long-run disability.
DC 7709's entry is one criterion and one note. The criterion: 100 percent with active disease or during a treatment phase. The note: a 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures; six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination; any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR 3.105(e); and if there has been no local recurrence or metastasis, rate on residuals under the appropriate diagnostic code(s). Read together that gives a claim under this code three distinct phases, only the first of which the tier describes. While there is active disease or treatment, the evaluation is total. For six months after treatment stops, it stays total by the note's own terms, whatever the examination findings are in that window. After the mandatory examination, the evaluation is either the total rating continuing because of local recurrence or metastasis, or it is an evaluation of the residuals under other codes entirely. Because 38 CFR 3.105(e) applies to any reduction, the move out of the total rating is a procedural event with its own requirements and not simply a new percentage. 38 CFR 4.31 supplies a 0 percent where the requirements for a compensable evaluation under this code are not met, which is the position of a veteran with no active disease, no treatment and no residual worth a compensable evaluation under another code.
- Diagnostic code
- 7709
- Rating schedule
- 38 CFR § 4.117
- Schedule levels
- 100%
How does the VA choose a rating level?
There is no higher or lower step inside this code: a rating decision either finds its criteria met or it does not. Where they are not met, 38 CFR § 4.31 assigns a 0% evaluation: service connection granted, at a level that does not pay.
EXPLORE THE PERCENTAGES
Hodgkin's Lymphoma VA rating criteria (DC 7709)
This condition has one published rating level. Read the criteria, then explore the details and monthly pay.
These are published rating criteria. Selecting a level does not predict your VA decision.
IN THE REGULATION’S OWN WORDS
What 38 CFR also says about Hodgkin's Lymphoma
The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.
- “Note: A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals under the appropriate diagnostic code(s)”DC 7709
BUILD YOUR EVIDENCE, ONE PIECE AT A TIME
Evidence for your Hodgkin's Lymphoma claim
A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.
Check off what you’ve gathered. Progress stays on this page until you leave or refresh.
THE EXAM FORM
Which DBQ is used for Hodgkin's Lymphoma?
VA's page says: “You can use these forms to submit medical evidence from your health care providers.”
Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.
SMALL DETAILS. BETTER PREPARATION.
Preparing your Hodgkin's Lymphoma claim
Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.
Practical tips for your claim4 tips
- 01
Put the date treatment stopped in writing and diary the six months from it. That is when the mandatory VA examination is due and when the evaluation can change.
- 02
Prepare the residual claims during those six months rather than after the examination. Cardiac, pulmonary, endocrine and neurological residuals of treatment each need evidence under their own codes.
- 03
Ask that the examination address local recurrence and metastasis explicitly. The note makes that the question the examination exists to answer.
- 04
Read 38 CFR 3.105(e) before accepting a reduction. The note applies it to any reduction based on the mandatory examination or any subsequent one.
C&P exam pitfalls to keep in mind4 tips
- 01
An examination six months out that reports remission and nothing else. The note asks whether there has been local recurrence or metastasis and, if not, directs a rating on residuals, so a report that stops at remission leaves the new evaluation unevidenced.
- 02
The date of discontinuance missing from the record. Without it the six-month period has no start, and the 100 percent has no defined end.
- 03
Residuals of treatment attributed to something else without being evaluated. They are what the note routes to the appropriate diagnostic codes, and they are frequently the lasting disability.
- 04
A reduction proposed without 38 CFR 3.105(e) being followed. The note applies it by name to any reduction based on the mandatory examination or a later one.
Common filing mistakes4 tips
- 01
Reading the 100 percent as permanent. The note schedules a mandatory VA examination six months after treatment is discontinued, and the evaluation from that point is determined by it.
- 02
Letting the claim lapse at remission. The schedule's instruction is to rate on residuals under the appropriate diagnostic codes, which is a continuing evaluation and needs its own evidence.
- 03
Filing the residuals under this code. They are rated under the codes for the body systems they affect, which is what makes a cardiac or pulmonary residual a separate evaluation rather than a tier here.
- 04
Assuming a six-month gap in treatment ends the total rating. The note continues the 100 percent beyond cessation of treatment for six months by its own terms, before any examination is read.
When symptoms may first appear2 tips
- 01
The schedule states no course of onset for this code. Its single criterion is written about a present state, active disease or a treatment phase, rather than about how the disease arose.
- 02
The interval the regulation fixes is six months, counted from discontinuance of treatment to a mandatory VA examination. What that examination evaluates, absent local recurrence or metastasis, is the residuals rather than the lymphoma.
LET’S CLEAR A FEW THINGS UP
Common questions about Hodgkin's Lymphoma
Is Hodgkin's Lymphoma a VA-rated disability?
Yes. The VA rates Hodgkin's Lymphoma under VASRD diagnostic code 7709 (Hemic and Lymphatic Systems). DC 7709 states one evaluation, 100 percent, for Hodgkin's lymphoma with active disease or during a treatment phase. Everything else about this code is in its single note, and the note is what a veteran needs: the 100 percent continues beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy or other therapeutic procedure, and six months after that treatment is discontinued a mandatory VA examination determines the rating. If there has been no local recurrence or metastasis, the evaluation moves to the residuals, rated under whatever codes they fall under — and for this disease the residuals of treatment are often the long-run disability.
What VA disability rating can I get for Hodgkin's Lymphoma?
Possible VA ratings for Hodgkin's Lymphoma are 100%, 0%. The 0% level comes from 38 CFR 4.31, which assigns it wherever no compensable level is met. Examples: 100%: With active disease or during a treatment phase.
What evidence helps prove Hodgkin's Lymphoma for VA disability?
Strong evidence for a Hodgkin's Lymphoma claim includes: The date treatment was discontinued. The note continues the 100 percent beyond cessation of treatment and starts a six-month period from that date, so it is the one date the evaluation turns on; Treatment records naming what was given. The note lists surgical therapy, radiation therapy, antineoplastic chemotherapy and other therapeutic procedures, and the continuation runs past the cessation of any of them; Evidence addressing local recurrence and metastasis, which is what the note asks the mandatory examination to establish before the evaluation moves to residuals; Records of the residuals by body system — cardiac, pulmonary, endocrine, neurological or otherwise. After the mandatory examination those are what is actually being rated, each under its own diagnostic code.
Which DBQ is used for Hodgkin's Lymphoma?
VA's Hematologic and Lymphatic Conditions, Including Leukemia Disability Benefits Questionnaire (DBQ) is on its public list of DBQs. VA's page says: "You can use these forms to submit medical evidence from your health care providers."
What mistakes should veterans avoid when claiming Hodgkin's Lymphoma?
Common pitfalls when filing for Hodgkin's Lymphoma: Reading the 100 percent as permanent. The note schedules a mandatory VA examination six months after treatment is discontinued, and the evaluation from that point is determined by it; Letting the claim lapse at remission. The schedule's instruction is to rate on residuals under the appropriate diagnostic codes, which is a continuing evaluation and needs its own evidence; Filing the residuals under this code. They are rated under the codes for the body systems they affect, which is what makes a cardiac or pulmonary residual a separate evaluation rather than a tier here; Assuming a six-month gap in treatment ends the total rating. The note continues the 100 percent beyond cessation of treatment for six months by its own terms, before any examination is read.
Is Hodgkin's Lymphoma a presumptive condition for VA benefits?
Yes, for a veteran who meets a presumption's conditions. 38 CFR 3.309(a) names "Hodgkin's disease" among the chronic diseases, for a veteran with 90 days or more of continuous active service in a war period or after December 31, 1946, if it became manifest to a degree of 10 percent or more within the window 38 CFR 3.307(a)(3) sets, one year from separation for most (38 CFR 3.307(a)(1)). 38 CFR 3.309(e) names "Hodgkin's disease" among the diseases associated with herbicide agents, for a veteran exposed to one during service. The regulation presumes that exposure for service in Vietnam, including its offshore waters, from January 9, 1962 to May 7, 1975; in a unit that, as the Department of Defense determined, operated in or near the Korean DMZ where herbicides were applied, from April 1, 1968 to August 31, 1971; or, in the Air Force or Air Force Reserve, regularly and repeatedly aboard C-123 aircraft used to spray herbicides (38 CFR 3.307(a)(6)). The statute, 38 U.S.C. 1116, 1116A and 1116B, also covers U.S. or Royal Thai bases in Thailand, Laos, Mimot or Krek in Cambodia, Guam or American Samoa or their territorial waters, Johnston Atoll or a ship that called there, and the DMZ from September 1, 1967, each in its own period. 38 U.S.C. 1120(b) names "Lymphoma cancer of any type" for a covered veteran: one who, on or after August 2, 1990, was assigned to a duty station in, or in the airspace above, Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia or the United Arab Emirates, or, on or after September 11, 2001, Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen or Uzbekistan (38 U.S.C. 1119(c)). Each presumption gives way to affirmative evidence to the contrary (38 CFR 3.307(d); 38 U.S.C. 1113).
Official sources
- 38 CFR § 4.117, Schedule of ratings, hemic and lymphatic systems (Diagnostic Code 7709)
- 38 CFR § 4.31, zero percent evaluations
- 38 CFR 3.309(a), presumptive service connection
- 38 CFR 3.309(e), presumptive service connection
- 38 U.S.C. 1120(b), presumptive service connection
Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.
How these figures are checked: our methodology and the open dataset.
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline